Inventor
Yongjuan GAO
Inventor
CN
Overview
Patents· 4 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes24%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations24%
C07KPeptides24%
C12NMicroorganisms or enzymes18%
A01KAnimal husbandry6%
Y02ATechnologies for adaptation to climate change6%
PatentTitleYear
11,833,212Linker peptide for constructing fusion protein202311,655,292Anti-human NGF antibodies and methods using same202311,472,863Human coagulation factor IX (FIX) fusion protein, preparation method therefor, and use thereof202211,471,513Highly glycosylated human blood-clotting factor VIII fusion protein, and manufacturing method and application of same2022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022–2023Patents assigned to AMPSOURCE BIOPHARMA SHANGHAI INC (4)· patent assignee history
2022Patents assigned to PHARMAB INC (2)· patent assignee history
2022Patents assigned to FUREN PHARMACEUTICAL GROUP CO LTD (1)· patent assignee history
2022Patents assigned to Kaifeng pharmaceutical group co ltd (1)· patent assignee history
2022–2023Based in CN· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| AMPSOURCE BIOPHARMA SHANGHAI INC | 4 | 2022–2023 |
| PHARMAB INC | 2 | 2022 |
| FUREN PHARMACEUTICAL GROUP CO LTD | 1 | 2022 |
| Kaifeng pharmaceutical group co ltd | 1 | 2022 |
Locations
| Location | Patents | Span |
|---|---|---|
| CN | 4 | 2022–2023 |